According to Nectar Lifesciences 's latest financial reports the company's total liabilities are โน10.97 Billion. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2024-03-31 | โน11.21 B | -0.25% |
2023-03-31 | โน11.24 B | -13.69% |
2022-03-31 | โน13.02 B | -1.75% |
2021-03-31 | โน13.26 B | -11.43% |
2020-03-31 | โน14.97 B | -6.42% |
2019-03-31 | โน15.99 B | -3.92% |
2018-03-31 | โน16.65 B | 5.78% |
2017-03-31 | โน15.74 B | -1.75% |
2016-03-31 | โน16.02 B | 4.88% |
2015-03-31 | โน15.27 B | 4.13% |
2014-03-31 | โน14.67 B | 4.31% |
2013-03-31 | โน14.06 B | 5.24% |
2012-03-31 | โน13.36 B | 22.44% |
2011-03-31 | โน10.91 B | 26.94% |
2010-03-31 | โน8.59 B | -12.46% |
2009-03-31 | โน9.82 B | 47.82% |
2008-03-31 | โน6.64 B | 19.44% |
2007-03-31 | โน5.56 B | 112.85% |
2006-03-31 | โน2.61 B |